Tosymra Spray
Product Images NDC 0245-0812

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Tosymra (NDC 0245-0812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tosymra 01)

Chemical structure diagram of sumatriptan, the active ingredient in TOSYMRA nasal spray. The structure shows the molecular arrangement of atoms including sulfonamide, indole, and dimethylamine functional groups.*

FDA Label Image

Figure A (Tosymra 02)

An instructional diagram labeled Figure A depicting a nasal spray device. It highlights the tip (nose), spray nozzle, and plunger (thumb) parts of the device, illustrating how it should be held and used for administration.*

FDA Label Image

Figure B (Tosymra 03)

An instructional illustration labeled Figure B shows a person holding a cloth or wipe against the chin and upper neck area with both hands, demonstrating a step in the product use or preparation process for a nasal spray medication.*

FDA Label Image

Figure C (Tosymra 04)

An instructional illustration showing a hand removing one nasal spray device from an open box containing multiple individual spray units. This figure highlights the step to remove only one device at a time from the packaging, relevant for the TOSYMRA nasal spray product.*

FDA Label Image

Figure D (Tosymra 05)

An instructional illustration showing a person holding an object near their eye, with an arrow pointing to a label displaying a lot number and expiration date. The image is labeled as Figure D, likely indicating where to find product lot and expiration information on packaging.*

FDA Label Image

Figure E (Tosymra 06)

An instructional illustration showing the steps to open a blister pack and prepare a nasal spray device. One hand is flipping over the blister packaging, and another hand is holding the nasal spray device after removal. The illustration is labeled "Figure E."*

FDA Label Image

Figure F (Tosymra 07)

An instructional illustration showing the proper nasal spray administration technique. The diagram depicts the spray device positioned inside a nostril with an arrow indicating the direction of spray delivery, labeled as Figure F.*

FDA Label Image

Figure G (Tosymra 08)

An instructional illustration showing a person holding their nose with a finger, likely demonstrating proper nasal spray use technique. The image highlights the lower part of the face and hand placement on the nose.*

FDA Label Image

Figure H (Tosymra 09)

Illustration showing a hand holding a nasal spray device, with fingers positioned on the spray actuator, labeled as Figure H. The image demonstrates the grip and application technique for administering a nasal spray.*

FDA Label Image

Figure I (Tosymra 10)

Illustration showing the correct usage angle for the nasal spray TOSYMRA 10 mg/0.1 mL (sumatriptan). The diagram directs to tilt the nasal spray outward during administration into the nostril, labeled as Figure 1.*

FDA Label Image

Figure J (Tosymra 11)

An instructional diagram illustrating the proper technique for using a nasal spray. It shows a person tilting their head back slightly while holding a nasal spray device near their nostril. An adjacent profile image indicates the head tilt angle by a curved arrow.*

FDA Label Image

Figure K (Tosymra 12)

An instructional diagram illustrating the use of TOSYMRA nasal spray. It shows a hand holding the spray device, pressing the plunger up, and a person inhaling through the nose as the spray is administered, with airflow indicated by dotted lines.*

FDA Label Image

Figure L (Tosymra 13)

An instructional diagram showing a side profile of a person demonstrating how to use a nasal spray. The person gently breathes in through the nose and out through the mouth, accompanied by visual arrows indicating airflow. A clock graphic suggests a 10 to 20 second timing for the action.*

FDA Label Image

Figure M (Tosymra 14)

Illustration depicting the proper disposal method for a nasal spray device, showing a hand placing the device into household trash, labeled as Figure M.*

FDA Label Image

Principal Display Panel (6 Bottle Blister Pack Carton)

Packaging label for TOSYMRA (sumatriptan nasal spray) 10 mg by Upsher-Smith Laboratories, LLC. The box indicates it contains six unit-dose nasal spray devices, each with 10 mg sumatriptan in 0.1 mL. The label features light blue and yellow floral designs with storage instructions and a barcode on the backside. The product is Rx only and for intranasal use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.